39th week of 2017 patent applcation highlights part 7 |
Patent application number | Title | Published |
20170273834 | ABSORBENT CORE - An absorbent core structure for disposable absorbent articles. The absorbent core having improved fluid handling properties. The absorbent core includes a first layer, a layer of absorbent polymer material, a layer of adhesive, and a second layer. The first layer has a first surface, a second surface, and a thickness of 0.4 mm to 1.5 mm. | 2017-09-28 |
20170273835 | ABSORBENT ARTICLE WITH HIGH ABSORBENT MATERIAL CONTENT - An absorbent article includes an absorbent core comprising a core wrap enclosing an absorbent material. The absorbent core further comprises at least one channel extending from the crotch region to the back region. The article further comprises an acquisition-distribution system (ADS) between the topsheet and the absorbent core. The ADS comprises one, two or more layers wherein the ADS does not comprise a layer comprising at least 50% by weight of synthetic fibers. | 2017-09-28 |
20170273836 | METHOD FOR MANUFACTURING ABSORBENT CORE HAVING ENHANCED WET STRENGTH - The present invention relates to an absorbent core of an absorbent product including a liquid-permeable top sheet, an absorbent dispersion layer disposed at a lower portion of the top sheet, an absorbent core disposed at a lower portion of the absorbent dispersion layer and absorbing and retaining liquids, and a liquid-impermeable back sheet disposed at a lower portion of the absorbent core, and the absorbent core has effects of having the convenience of storage and the activity when an absorbent product prepared therefrom is worn by a user and improving liquid permeability compared to an existing absorbent core. | 2017-09-28 |
20170273837 | Wound Care Accessory Device - A wound care accessory device providing pre-cut tape and an infection control barrier includes a sheet that comprises a first section and a second section. The sheet is substantially rectangularly shaped. A plurality of tape strips is disposed on and peelable from the second section of the sheet. The sheet is configured for placement proximate to a wound that requires care. The sheet provides a barrier to control infection. The first section is configured for placement of accessories used in caring for the wound. The tape strips are positioned on the second section of the sheet. The strips are configured for peeling by the user from the sheet to be used in caring for the wound. | 2017-09-28 |
20170273838 | RECONFIGURATION MEANS FOR A WHEELCHAIR - Means for reconfiguring a wheelchair are disclosed wherein a user or an occupant of the wheelchair is enabled to repeatably alternate the wheelchair between an original load-bearing configuration and a modified load-bearing configuration by engaging and disengaging a ground-contacting adaptive implement operatively connected to a load transitioning mechanism, said load transitioning mechanism adapted for connection to a forward portion of the wheelchair. Embodiments according to the present invention enable an occupant of the wheelchair to alternate the wheelchair, through a cyclic operation sequence, between the original configuration and the modified configuration by toggling of a manipulable switch and subsequent momentary reclining of the wheelchair. The user willfully effectuates a change in the angular disposition of the ground-contacting adaptive implement relative to the wheelchair about a substantially horizontal joint axis wherein in the modified configuration a deployed angular orientation is maintained under load-bearing conditions during travel of the wheelchair in all directions. Embodiments of the present invention enable wheelchair reconfiguration with simplicity of operation while ensuring rigid attachment of a ground-contacting adaptive implement to the wheelchair to confer special functionalities to the wheelchair while preserving comfort and safety for the user while the wheelchair is in the modified load-bearing configuration. | 2017-09-28 |
20170273839 | WHEELCHAIR INCLUDING ACCOMMODATION POCKET - A wheelchair is provided includes driving wheels, a pair of side frames, and an accommodation pocket. The frames rotatably support the driving wheels coupled to the exterior sides of the side frames. Each of side frames includes an elbow rest frame portion, a vertical frame portion, and a lower frame portion. The elbow rest frame portion has an elbow rest. The vertical frame portion is coupled to the rear end part of the elbow rest frame portion. The lower frame portion is arranged under the elbow rest frame portion. The vertical frame portion is coupled to the rear end part of the lower frame portion. The accommodation pocket is arranged above the front part of the driving wheel as viewed in side view, and is at least partially positioned on the exterior side relative to the elbow rest frame portion as viewed in front view. | 2017-09-28 |
20170273840 | ADJUSTABLE WHEELCHAIR ARRANGEMENTS - An adjustable wheelchair includes a base frame having a first guide portion defining a first arcuate channel, and a seat frame having a second guide portion defining a second arcuate channel confronting the first arcuate channel. A first bearing assembly is secured to a front end of the first arcuate channel and extends into bearing engagement with the second arcuate channel. A rear bearing assembly is secured to a rear end of the second arcuate channel and extends into bearing engagement with the first arcuate channel. The seat frame is slideable in an arcuate path defined by the first and second arcuate channels for adjustment of a tilt angle of the seat frame with respect to the base frame. | 2017-09-28 |
20170273841 | Mobility Device for Easy Transfer of Physically Challenged Individuals and Methods of Use - The present invention provides a mobility device and methods of use to easily and quickly transfer a physically challenged individual from one seat to another seat. The mobility device and methods of use of the present invention also facilitates moving the physically challenged individual from one seat located at one location to another seat located at another location. | 2017-09-28 |
20170273842 | EXTENDABLE FLUID CONDUIT FOR RECONFIGURABLE BED - A patient support system including a frame having first and second portions, at least one of them movable with respect to the other to transition the frame between a first configuration and a second configuration. A first port is coupled to the first portion of the frame, and a second port disposed with the second portion of the frame, such that a distance between the first port and the second port changes when the frame transitions between the first and second configurations. A fluid conduit is arranged between the first port and the second port and configured to transition between a first length and a second length, longer than the first length, when the frame is transitioned between the first and second configurations. The fluid conduit is configured with a resiliency to naturally return toward the first length. A method of using a patient support system is also included. | 2017-09-28 |
20170273843 | ARTICLE FOR COLLECTING THE URINE AND STOOLS OF A USER - An article ( | 2017-09-28 |
20170273844 | Patient Isolation Tent - A patient isolation tent is disclosed. The tent includes a free-standing frame assembled from individual frame components and corner connectors. A thin, flexible, substantially transparent, disposable membrane having a bottom surface, four side surfaces, and at least partially open top connects to and is supported by the frame to define a patient isolation space. The membrane is formed as a single, continuous piece of material with integral gloves, interior instrument pockets, and a waste catchment. In use, the bottom surface of the membrane in a collapsed folded or unrolled state overlays a patient support. A patient lays on the support and the side surfaces of the membrane are extended to an upright position to create a patient isolation space. When the patient's isolation period or treatment is completed, the membrane and any patient bodily fluids in the waste catchment are properly disposed of The frame may be disassembled, and the frame and patient support may be reused. The entire patient isolation tent may be provided as a compact kit for ready shipment to and use in remote locations. | 2017-09-28 |
20170273845 | SYSTEM AND METHOD FOR REDUCING AIRBORNE MICROBES - Systems and methods of reducing airborne contaminants, such as airborne microorganisms, including bacterial, viral, and fungal microbes, in an indoor space are disclosed. The method includes positioning a portable photo-catalytic oxidation system proximate a source of contaminants in the indoor space and activating the photo-catalytic oxidation system to circulate air through the photo-catalytic oxidation system at a rate ranging from approximately 16 to approximately 24 air exchanges per hour in the indoor space. The photo-catalytic oxidation system is configured to oxidize contaminates in the air. | 2017-09-28 |
20170273846 | Femoral Lift Apparatus - A femoral lift apparatus for an operating table having a side rail, the apparatus engageable with the femur of a patient. The apparatus includes a lift mountable to the side rail. An extension arm is receivable on the lift, the extension arm extending transversely from the lift when the extension arm is received on the lift. A plurality of apertures can be defined along the extension arm, and a femoral hook can be receivable in one of the apertures in the extension arm, the femoral hook having a hook end shaped to be received under and contour the femur of the patient positioned on the operating table when the lift is mounted to the side rail of the table, the extension arm is received on the lift, and the femoral hook is received in one of the apertures of the extension arm. | 2017-09-28 |
20170273847 | Tandem Casket System with Interconnecting Passageway to Accommodate Handholding of Deceased Persons - A tandem casket system includes two caskets disposed side by side. Interconnecting the two caskets is a passageway in which the hands of occupants of the caskets can be joined. | 2017-09-28 |
20170273848 | Multifunctional curved board - A multi-functional curved board to be used when working in standing position and for working when sitting down as a support for feet and generally for maintaining muscle strength, the multi-functional curved board having at least one curved body ( | 2017-09-28 |
20170273849 | ACTIVE RECORERY SYSTEM AND METHOD HAVING CAPACITIVE PROXIMITY SENSOR - A shoe has a sole having a capacitive sensor and a force actuating mechanism, and a wireless receiver. The capacitive sensor can detect and sense whether or not there is a foot is in the shoe. The force actuating mechanism can operate like a piston in an inactive mode (first position) and active mode (second position), wherein the active mode extends the force actuating mechanism's extending mechanism from first position to second position. The wireless receiver can retrieve any information in regards to geodetic locations from the capacitive sensor based on the capacitance signal. | 2017-09-28 |
20170273850 | TRIGGER POINT THERAPY DEVICE - A trigger point therapy device for applying pressure to a localized area of myofascial tissue that is accessed from the exterior of a patient's body. The therapy device includes a base portion has top and bottom surfaces that define a width dimension for the base portion. The therapy device also includes a pressure applicator that is connected to the base portion. The device allows an equivalent amount of pressure to be applied while the patient is lying on a soft surface as compared to lying on a hard surface. This increases the length of time that a patient will can comfortably use the device and promotes usage of the device by the patient. A method includes placing the device on a soft surface and positioning a patient on the soft surface to place the pressure applicator in engagement with the localized area of myofascial tissue. | 2017-09-28 |
20170273851 | COMPRESSION GARMENT FOR NEUROLOGICAL AND CIRCULATORY DISORDERS - A compression garment for a neurological disorder includes a body portion and a pad. The body portion may be operable to wrap around a foot and the pad can attach to an inner surface of the body portion. The pad can include an outward protrusion and/or an inward recess. A guide sleeve may be dimensioned to wrap together with the body portion around the foot, the pad being disposable between the body portion and the guide sleeve. A first tensioning band may be attached onto to first and second locations of the body portion and be operable to secure opposing first and second portions of the inner surface of the body portion to secure the outward protrusion and/or recess of the pad against the abductor hallucis and flexor hallucis brevis muscles of the foot. The outward protrusion can include a receiver for the metatarsal head. | 2017-09-28 |
20170273852 | WALKING ASSISTANCE APPARATUS AND WALKING TRAINING METHOD - A walking assistance apparatus includes stimulus applying means for applying a stimulus to a leg part on which a walking assistance apparatus is mounted and state detection means for detecting a supporting leg condition and a lifted leg condition of the leg part on which the walking assistance apparatus is mounted. The stimulus applying means applies a first stimulus to the leg part when the state detection means has detected that the leg part on which the walking assistance apparatus is mounted is in the lifted leg condition, and the stimulus applying means does not apply a stimulus to the leg part or applies a second stimulus that is weaker than the first stimulus when the state detection means has detected that the leg part on which the walking assistance apparatus is mounted is in the supporting leg condition. | 2017-09-28 |
20170273853 | CONTROLLER FOR MOTION ASSISTING APPARATUS, MOTION ASSISTING APPARATUS, METHOD FOR CONTROLLING MOTION ASSISTING APPARATUS, AND RECORDING MEDIUM - A controller for a motion assisting apparatus for a wearer includes circuitry. The circuitry is configured to set switching points in a change in a turning angle of a drive mechanism driven by a drive motor and attached to an ankle joint of the wearer to assist a turning motion of the ankle joint, a ratio of the change in the turning angle being equal to zero at the switching points. The circuitry is configured to set a motion pattern such that the turning angle monotonically increases or monotonically decreases between the switching points. The circuitry is configured to control the drive motor to change the turning angle according to the motion pattern. | 2017-09-28 |
20170273854 | ELECTRIC WALKING AID AND CONTROL METHOD THEREOF - An electric walking aid and control method thereof are disclosed. A location of the electric walking aid, and a distance between the electric walking aid and the user, are dynamically controlled and adjusted to provide the user with static and dynamic support function, so as to support the user under static and dynamic situation of interaction between walk and stand, during the walking training process. | 2017-09-28 |
20170273855 | DO-IT-YOURSELF MASSAGER - A massager includes a massaging bar and a handle. The massaging bar includes a shank and a massaging block. The shank has a first end connected with the handle and a second end formed with a curved section. The curved section has a distal end formed with an inward bending portion which bends and extends toward the shank. The inward bending portion has a hook-shaped profile, with a bending angle being defined between the inward bending portion and the curved section. The massaging block is mounted on the inward bending portion. Thus, the inward bending portion has the bending angle with a determined orientation, so that the inward bending portion can exactly transmit a user's force to the massaging block of the massaging bar, such that the massaging block can press the user's back actually. | 2017-09-28 |
20170273856 | COPPER MASSAGER THERAPY TOOL - A hand held massage tool that is used for the therapy of muscles and tendons that are suffering from tightness, knots and overall soreness. It can be used as a preventative measure to help keep muscles and tendons stretched. Treatment includes a rubbing back and forth and rolling motion by the copper massage tool directly on the muscle and tendon area that is being focused on. The massage tool is comprised of copper tubing that is filled with liquid to provide the benefit of a thermal transfer of hot and cold properties achieved by the liquid from inside and around the outside of the copper tube for massage therapy treatments. The copper tube generates heat by friction and is also heated and cooled by external sources. | 2017-09-28 |
20170273857 | MASSAGING APPARATUS - A massaging apparatus has two massaging systems arranged proximate to each other for performing more elaborate massage on target body areas. The massaging apparatus includes a first massaging member pair for massaging target areas; a second massaging member pair, provided independently of the first massaging member pair, for massaging target areas; a rotation shaft rotatably driven; a paired first conversion mechanisms, each disposed on a corresponding one of the first massaging members, for converting rotation of the rotation shaft into mutually approaching and separating movements of the first massaging members; and a second conversion mechanism for converting rotation of the rotation shaft into mutually approaching and separating movements of the paired second massaging members. The second massaging member pair is disposed between the paired first massaging members, and the second conversion mechanism is disposed between the paired first conversion mechanisms. | 2017-09-28 |
20170273858 | Method and Apparatus for Affecting Wellness Through Topical Application of Hand-held Rods - A method and apparatus for affecting wellness in a person's body are provided. More particularly, the apparatus for affecting wellness comprises one, or even two, cylindrical rods comprising minerals and other materials defined, in some embodiments, by high specific heat and low conductivity so that the rods are able transfer heat to a person's body relatively slowly. Methods are disclosed which direct particular applications of such rods, or wands, on the body in order to locally stimulate muscles and circulation to relieve and/or treat various conditions. | 2017-09-28 |
20170273859 | Massaging Device - Disclosed herein is a massage device configured to provide a squeezing pressure. The massage device may include an elastically extensible and bendable connector element and at least two rolling massage elements. A portion of the elastically extensible and bendable connector element and the at least two rolling massage elements form a massaging zone configured to receive one or more body parts. The body parts may include feet, forearms, and the like. Accordingly, the massage device may provide relief for specific conditions such as plantar fasciitis and carpel tunnel syndrome. | 2017-09-28 |
20170273860 | APPARATUS, SYSTEM, AND METHOD FOR TESTING AND EXERCISING THE PELVIC FLOOR MUSCULATURE - An apparatus for testing and exercising pelvic floor musculature, the apparatus comprising an elongate housing adapted for a pelvic floor aperture. The housing accommodates an oscillator and an accelerometer connected to a signal processor configured for communicating signals representative of values read from the accelerometer. A result is calculated from an applied oscillation and a response measured, and used for characterizing the musculature. In one embodiment the frequency resulting in the greatest response from the musculature is measured, and this frequency is applied during exercise. | 2017-09-28 |
20170273861 | SYSTEMS AND METHODS FOR WIRELESSLY CONTROLLED STIMULATION - A system for providing stimulation is provided configured for wireless communication sufficient to control a stimulator when the stimulator is positioned between the bodies of two users. The system includes a stimulator configured for positioning proximate to erogenous areas of two users, providing physical stimulation to the two users by way of the erogenous areas the two users, and wirelessly receiving one or more control signals controlling one or more characteristics of the provided physical stimulation; and a remote controller configured for wirelessly transmitting the one or more control signals to the stimulator, the remote controller adapted for transmitting electronic signals representative of the one or more control signals using a wireless frequency capable of maintaining a quality of signal sufficient to control operation of the stimulator during transmission through organic tissue of both of the users. | 2017-09-28 |
20170273862 | SYSTEMS AND METHODS FOR STIMULATING SWALLOWING - A device includes a first vibrational transducer and a second vibrational transducer. The first vibrational transducer has a first vibrating property. The second vibrotactile stimulator has a second vibrating property different than the first vibrating property. A collar may be configured to position the first vibrational transducer and the second vibrational transducer over a neck of a subject. A method for stimulating swallowing in a subject includes applying a first vibrotactile stimulation and applying a second vibrotactile stimulation to a throat area of the subject. The first vibrotactile stimulation has a first vibrating property and the second vibrotactile stimulation has a second vibrating property different than the first vibrating property. Example vibrating properties include vibrating frequency, vibrating frequency range, wave shape, continuousness, frequency phase, and direction of mechanical force. | 2017-09-28 |
20170273863 | Gastrointestinal Capsule and Treatment Method - A gastrointestinal capsule (GIC) including a capsule housing having a longitudinal axis; a thrusting mechanism, disposed within the housing; and a battery adapted to power the and a battery adapted to power the thrusting mechanism; the thrusting mechanism having an active mode, and a passive mode with respect to the active mode, the thrusting mechanism adapted to exert a radial force on the housing, in a radial direction with respect to the axis, such that when the capsule is disposed within a gastrointestinal tract of a user, and the mechanism is in the active mode, the gastrointestinal capsule stimulates a wall of the tract; the active mode including a series of at least two pulses of the radial force, the series having a first duration, the passive mode having a second duration, wherein an activation cycle is defined by the series of pulses followed by the second duration. | 2017-09-28 |
20170273864 | Real-Time Kinematic Analysis During Cardio-Pulmonary Resuscitation - Systems and methods related to the field of cardiac resuscitation, and in particular to devices for assisting rescuers in performing cardio-pulmonary resuscitation (CPR) are described herein. The system includes a camera to capture one or more images at a scene where the person in need of medical assistance is being treated and one or more processors. The processors receive and process the images, by using a rescuer profile, to provide a real-time feedback to the rescuer to improve the CPR treatment. | 2017-09-28 |
20170273865 | ROTATING CONTROL PANEL - Disclosed herein are systems, methods, and devices for implementing a rotating control panel. Systems include an enclosed space of a sauna comprising a plurality of walls, an opening in at least one of the plurality of walls, and a control panel configured to be coupled with at least one heating element. The control panel includes an axis of rotation and a plurality of controls. Systems also include a rotating mount coupled with the control panel at the axis of rotation to enable the control panel to rotate at least 180 degrees within the opening of the a wall of the enclosed space of the sauna without disconnecting the at least one electrical connector. Systems include an insulating seal coupled with the control panel and configured to contact the opening when the control panel is coplanar with the wall while allowing the control panel to rotate freely within the opening. | 2017-09-28 |
20170273866 | TOE CORRECTOR - A toe corrector is provided including: a floor part; correction protrusions protruding between each toe from an upper surface of the floor part to correct the toes; a connection part for connecting the upper ends of the correction protrusions so that correction protrusions are put on toes to be fixed; and light emitting units for emitting light by independently generating electricity, which are provided inside the correction protrusions and on the floor part. | 2017-09-28 |
20170273867 | SECURE MEDICATION DELIVERY - A method includes micro-machining a cavity within a substrate, filling the cavity with a medication, forming a sealing layer over the cavity, micro-machining a cantilevered beam from a layer of material, the cantilevered beam comprising a tip for puncturing the sealing layer, and attaching the cantilevered beam to the substrate such that moving the cantilevered beam toward the substrate enables the tip to puncture the sealing layer. A computer program product corresponding to the method is also disclosed. An apparatus includes a substrate having a cavity micro-machined therein, a sealing layer formed over the cavity, a medication disposed within the cavity, a cantilevered beam micro-machined from a layer of material, the cantilevered beam comprising a tip for puncturing the sealing layer, and the cantilevered beam attached to the substrate and disposed to enable the tip to puncture the sealing layer when the cantilevered beam is moved towards the substrate. | 2017-09-28 |
20170273868 | DEVICE FOR CUTTING MEDICINE TABLET - A device for cutting a medicine tablet includes a base extending along an axis, a cutting device having a fixed cutter and a movable cutter base, and a carrying plate movably disposed inside the base and having a carrying face for a medicine tablet. The fixed cutter is fixedly disposed inside the base, the movable cutter base is optionally positionably moves between protruding and retreating positions axially, the movable cutter base has a movable cutter, when the movable cutter is in the protruding position, a blade of the movable cutter is near a blade of the fixed cutter, and when the movable cutter base is in the retreating position, the blade of the movable cutter is remote from the blade of the fixed cutter. The carrying face faces the blade of the fixed cutter and is able to approach the blade of the fixed cutter. | 2017-09-28 |
20170273869 | MEDICINE CASSETTE AND MEDICINE FEEDING APPARATUS - A medicine feeding apparatus includes a cylindrical body | 2017-09-28 |
20170273870 | ANIMAL SUPPLEMENTS OR MEDICATION ORGANIZER - The disclosure is directed at an animal supplements and/or medication organizer that includes a tray and a plurality of containers containing the supplements and/or medication. The plurality of containers can be different sizes to hold the supplements and/or medication, either in a solid (powdered or liquid) form. The tray includes a predetermined number of sections for receiving the containers. | 2017-09-28 |
20170273871 | SORTING PILLBOX - The present invention provides a modular dispenser for organizing solid dosage preparations. An innovative lid concept provides a space to layout and inspect an incremental count of solid dosage preparations preliminary to committing them to compartment storage with minimal manipulative effort. Mnemonic devices, such as indicia, color-coded lids, and a mobile device app facilitate remembering event times. Releasable mounting and modular construction facilitates the staging of individual compartments for travel and sequencing purposes. | 2017-09-28 |
20170273872 | BABY FORMULA CONSUMPTION BOTTLE - A bottle for baby formula that includes: a main liquid portion; a formula portion attached to the liquid portion, where the formula portion includes an infant formula for consumption and is adapted for removal; an attachment means that provides a means to attach the formula portion to the liquid portion of the bottle; a nipple; and a removable cap, where the removable cap covers the nipple. Preferably, the attachment means is a threaded connection and the liquid portion includes a curved outer surface. The infant formula may be a premixed powder mixable with water. | 2017-09-28 |
20170273873 | TUBE SUPPORT - A support for supporting a portion, external to a patient, of a tube partly embedded in the patient. The support includes a torso embracing portion for embracing a torso of the patient. The support also includes one or more tube holding portions for holding the tube. The tube holding portion(s) are fixable to, or part of, the torso holding portion. | 2017-09-28 |
20170273874 | ORAL BIOFILM INHIBITOR - There is provided an oral biofilm inhibitor having an exceptional inhibitory effect on oral biofilm formation. It is an oral biofilm inhibitor comprising a curable composition containing an antimicrobial agent, wherein a compressive strength of a cured product formed by curing the composition is 150 MPa or less, and a content of the antimicrobial agent is 0.001 to 3% by weight. An oral biofilm inhibitor thus obtained is used for inhibiting biofilm formation in an oral cavity by applying a curable composition containing an antimicrobial agent to a dental defect site for allowing the composition to cure at the dental defect site, and then disintegrating the cured composition. | 2017-09-28 |
20170273875 | CORE-SHELL PARTICLE - There is provided a core-shell particle comprising a polymer conjugate encapsulating an active agent, wherein the polymer conjugate comprises a biocompatible polymer and a polyacidic polymer. There is also provided a process for forming the core-shell particle, a delivery vehicle comprising the core-shell particle and a method for delivering an active agent to a desired site. | 2017-09-28 |
20170273876 | BENEFIT DELIVERY PARTICLE - A hydrogel particle, comprising: a) a matrix, and b) a silicone or blend or silicones, wherein the silicone or blend of silicones has an average molecular weight of greater than 400 Da, and wherein the particle has an average diameter of 0.1 to 15 mm and wherein the silicone is present in an amount of from 5 to 40 wt %, preferably from 25 to 40 wt % by total weight of the particle. | 2017-09-28 |
20170273877 | CAPSULE AGGREGATES - The aggregates each contain two or more benefit particles each containing an active material and a polymeric material that immobilizes the active material; one or more binder polymers each having an anionic chemical group that is negatively charged or capable of being negatively charged; and one or more deposition polymers each having a cationic chemical group that is positively charged or capable of being positively charged. Also disclosed are a process of preparing the aggregates, related capsule compositions, and a consumer product containing such an aggregate. | 2017-09-28 |
20170273878 | KERATINOUS FIBER TREATMENT PRODUCT AND METHOD - A cosmetic product includes a) a cosmetic preparation including, in relation to the total weight of the preparation, a1) 60 to 94 wt % polar solvent; a2) 0.1 to 20 wt % oxidant; and b) a device for flash-evaporating the cosmetic preparation a). A method for changing the color of keratinous fibers incorporates such a product. Particularly, the cosmetic preparation a) is used as a process material in a flash evaporation device. | 2017-09-28 |
20170273879 | THICKENING DEVELOPER FOR OXIDATION DYES - A composition for oxidative hair treatment, containing 50-96% by weight; 0.5-20% by weight hydrogen peroxide; at least one polyethylene glycol ether of a monoester of glycerol and a C12-C22 carboxylic acid having 110-500 ethylene oxide units in the molecule, according to formula (I), wherein the sum of the indices x+y+z stands for a number in the range of 110 to 500, and R stands for an alkyl functional group having 11 to 21 carbon atoms, which may be saturated or unsaturated, linear or branched, wherein all stated quantities are based on the weight of the oxidation composition. Wherein the composition is suited for use as a developer for oxidative hair lighteners and/or hair dyes. The alkaline composition (A) is present as an oil-in-water emulsion and includes at least one alkalizing agent, and has a pH in the range of 8 to 11.5. | 2017-09-28 |
20170273880 | Hair Care Compositions Comprising Malodor Reduction Compositions - The present invention relates to hair care compositions comprising malodor reduction compositions and methods of using such hair care compositions. Such hair care compositions comprising the malodor control technologies disclosed herein provide malodor control without leaving an undesirable scent and when perfume is used to scent such compositions, such scent is not unduly altered by the malodor control technology. | 2017-09-28 |
20170273881 | COSMETIC COMPOSITION FOR KERATIN FIBRES - The present invention relates to a cosmetic composition based on glyoxylic acid and/or derivatives in foam form able to reshape the form of keratin fibre, and a method of reshaping the form of keratin fibre with said composition. | 2017-09-28 |
20170273882 | COMPOSITION AND METHOD FOR TREATING KERATIN FIBERS WITH FLASH EVAPORATION - A cosmetic product includes a cosmetic preparation including, in relation to the total weight thereof, 35 to 85 wt % polar solvent and 0.001 to 10 wt % oxidation dye precursor. The cosmetic product also includes b) a device for flash evaporation of the cosmetic preparation a). A method incorporates the use of the corresponding product and particularly the use of the cosmetic preparation a) as a process material in a device for flash evaporation. | 2017-09-28 |
20170273883 | METHOD FOR TREATING AND COLORING HAIR COMPRISING UN-PIGMENTED HAIR - Described herein is a method for treating and coloring hair including un-pigmented hair. The method includes (a) providing a first composition including one or more heavy metal ion sequestrants; (b) applying the first composition to the hair; (c) providing a second composition including one or more weak acids having a pKa from 2.5 to 5; (d) applying the second composition to the hair; (e) providing a third composition including one or more direct dyes chosen from nitro dye, disperse dye, cationic dye, acid dye, basic dye, neutral azo dye and mixtures thereof, and (f) applying the third composition to the hair. The third composition is able to decrease the reflectance of un-pigmented hair in a wavelength range from 530 nm to 670 nm. | 2017-09-28 |
20170273884 | COMPOSITION COMPRISING A DICARBONYL COMPOUND AND METHOD FOR SMOOTHING THE HAIR USING THIS COMPOSITION - The present invention relates to a composition comprising:
| 2017-09-28 |
20170273885 | METHODS OF PRODUCING LIGNIN PEROXIDASE AND ITS USE IN SKIN AND HAIR LIGHTENING - Methods of producing lignin peroxidase are provided. Also provided are methods and cosmetic compositions suitable for skin and hair lightening as well as kits and an article-of manufacturing including active ingredients for skin and hair lightening. | 2017-09-28 |
20170273886 | STABLE HYDROGEL COMPOSITIONS INCLUDING ADDITIVES - The present specification generally relates to an injectable dermal filler composition that includes crosslinked hyaluronic acid-based polymer and an antioxidant. | 2017-09-28 |
20170273887 | COMPOSITE POWDER, METHOD OF PRODUCING THEREOF AND COSMETIC COMPOSITION CONTAINING THE SAME - The present invention relates to a method of producing a composite powder. A porous powder is physically covered by collagen and chitosan sequentially, thereby forming the composite powder. The composite powder has good dispersity, an ability of moisture retention and a low greasiness while being added in an oil-in-water emulsion base or a hydrogel base to form a cosmetic composition. | 2017-09-28 |
20170273888 | BIODEGRADABLE MICROSPHERES - The present disclosure describes a plurality of microspheres that include carboxymethyl chitosan (CCN) crosslinked with carboxymethyl cellulose (CMC). The microspheres are biocompatible, bioresorbable, and biodegradable. The microspheres may be used in personal care products, such as, for example, toothpaste, topical pain relief products, topical antibiotic products, skincare products such as anti-wrinkle products, eczema products, skin scrubs, acne cleansers, exfoliators, body washes, soaps, pre-shave creams, or the like. | 2017-09-28 |
20170273889 | AGENT AND METHOD FOR THE TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS - The disclosure relates to a cosmetic product, comprising a) a cosmetic preparation, containing, in relation to its total weight, a1) 45 to 98 wt.-% of at least one polar solvent; a2) 0.1 to 4.0 wt.-% of chitosan; and a3) 0.1 to 15 wt.-% of a film-forming polymer; b) a device for flash evaporation of the cosmetic preparation a), and to a method using corresponding products and the use of the cosmetic preparation a) as process material in a device for flash evaporation. | 2017-09-28 |
20170273890 | TRANSPARENT COMPOSITIONS - A composition comprising: A) a transparent gel base, comprising: a) a polymeric thickener, b) a solubiliser, c) a pH adjuster, d) a calcium sequestrant, e) water, f) an optional protein, g) an optional active material, which is selected from disaccharides, lactones, inorganic salts, diacids and mixtures thereof, h) an optional dye preferably comprising violet, blue, red or mixtures thereof, wherein the solubiliser comprises a mixture of at least two components, said mixture comprising at least one high HLB component having an HLB value of from 10 to 20 and at least one low HLB component having an HLB value of from 1 to less than 10, and B) a hydrogel particle, comprising: a) a matrix, and b) a silicone or blend of silicones, wherein the silicone or blend of silicones has an average molecular weight of greater than 400 Da, and wherein the particle has an average diameter of 0.1 to 15 mm and wherein the silicone is present in an amount of from 5 to 40 wt % by total weight of the particle. A method of treating a substrate includes contacting the substrate with the composition and applying a releasing force to the hydrogel particle to release the silicone. | 2017-09-28 |
20170273891 | COMBINED CARE AND STYLING AGENT HAVING A HEATING ELEMENT EFFECT - Cosmetic composition having a heating effect and used for the care and temporary shaping of keratin fibers and related methods are provided. The cosmetic composition can include at least one polyethylene glycol comprising 4 to 20 oxyethylene units; a copolymer composed of hydrogenated castor oil and an n-alkyl dicarboxylic acid comprising 4 to 10 C atoms; and at least one film-forming agent. | 2017-09-28 |
20170273892 | CLEAR HAIR CONDITIONER COMPOSITION - A hair conditioner which provides hair conditioning, de-tangling, frizz control and reduced flyaway benefits, without weighing down hair or loosing hair volume, in a clear composition, is disclosed. The composition utilizes a combination of high levels of PEG/PPG silicone surfactants together with cationic polymeric thickeners (such as polyquaternium-37) to provide those benefits. | 2017-09-28 |
20170273893 | AGENT FOR TEMPORARY SHAPING OF KERATIN-CONTAINING FIBERS HAVING A MIXTURE OF CONDITIONING POLYMERS - A transparent cosmetic composition and related methods are provided. The composition includes, in relation to the total weight thereof, 0.1 to 30 wt. % of a mixture of at least two conditioning polymers, 0.01 to 25 wt. % of a polyether-modified polysiloxane, 0.001 to 15 wt. % of a film-forming polymer, and 1 to 90 wt. % water. | 2017-09-28 |
20170273894 | COSMETIC COMPOSITIONS AND USES THEREOF - The present invention relates generally to methods and compositions comprising | 2017-09-28 |
20170273895 | ORAL HEALTH IMPROVING COMPOSITIONS - The present invention is concerned with microorganisms or fragments thereof as sensorically neutral oral care agents, particularly for prevention of dental calculus, as anti-caries agents and/or anti-oral malodor agents. The invention is furthermore concerned with compositions comprising microorganisms or fragments thereof for reducing | 2017-09-28 |
20170273896 | CONTROLLED EXTENDED RELEASE PREGABALIN - A controlled extended release composition comprising at least one unit dosage form having at least one active pharmaceutical ingredient (API), wherein said at least one API comprises at least one of pregabalin, a base thereof, a pharmaceutically acceptable prodrug thereof, a pharmaceutically acceptable derivative thereof, a pharmaceutically acceptable complex thereof, a pharmaceutically acceptable salt thereof, a pharmaceutically acceptable polymorph thereof, a pharmaceutically acceptable hydrate thereof, a pharmaceutically acceptable solvate thereof, an enantiomer thereof and a racemate thereof. Methods and uses of the composition are provided. | 2017-09-28 |
20170273897 | COMPOUNDED TOPICAL COMPOSITION AND METHOD - A compounded topical composition may include an antiviral component, a topical base component, and a local anesthetic component. The antiviral component may include fine powder obtained by grinding oral tablets of one or more antiviral actives. The topical component may include the local anesthetic component. The local anesthetic component may be present in an amount between about 2% and about 8% by weight of the compounded topical composition and the antiviral component may be present in an amount between 4% and 12% by weight of the compounded topical composition. The antiviral component may include acyclovir, valaciclovir, penciclovir, famciclovir, or combinations thereof, and the topical base component may be a lidocaine topical, a lidocaine and prilocaine topical, or both. | 2017-09-28 |
20170273898 | COMPOUNDED TOPICAL COMPOSITION AND METHOD - A compounded topical composition may be compounded by combining a local anesthetic component with a topical base composition. The local anesthetic component may comprise lidocaine hydrochloride monohydrate and the topical base composition may comprise an Acyclovir 5% Ointment containing 5% acyclovir by weight and polyethylene glycol. | 2017-09-28 |
20170273899 | INTRAVAGINAL DEVICES FOR CONTROLLED DELIVERY OF LUBRICANTS - The present technology provides intravaginal devices designed to deliver lubricants to the vagina for a sustained period of time. The intravaginal devices include a first segment comprising an outer surface and a lumen containing a lubricant, wherein the first segment is configured to deliver the contents of the lumen to the outer surface, and the first segment comprises a polymer selected from the group consisting of a hydrophilic, semi-permeable elastomer and a hydrophobic elastomer. The lubricant may be an aqueous lubricant. The present technology further provides an intravaginal device including a solid first segment that includes a hydrophilic semi-permeable elastomer, an outer surface and an aqueous lubricant, wherein the first segment is configured to deliver the aqueous lubricant to the outer surface. | 2017-09-28 |
20170273900 | METHODS FOR MANUFACTURING IMPLANTS - Pharmacologically active implants, in particular subcutaneous implants, intrauterine devices, and intravaginal rings, are provided herein. Methods for forming an active ingredient-containing core are described. Methods for laminating an active ingredient-containing core to form a rate-controlling sheath are also described. | 2017-09-28 |
20170273901 | SUNITINIB FORMULATIONS AND METHODS FOR USE THEREOF IN TREATMENT OF OCULAR DISORDERS - Methods for increasing the encapsulation or incorporation of Sunitinib into polymeric matrices have been developed. The resulting formulations provide for more sustained controlled release of sunitinib or its analog or a pharmaceutically acceptable salt thereof. Increased loading is achieved using an alkaline solvent system. The pharmaceutical compositions can be administered to treat or prevent a disease or disorder in or on the eye of a patient associated with vascularization, such as corneal neovascularization and acute macular degeneration. Upon administration, the sunitinib or its analog or salt is released over an extended period of time at concentrations which are high enough to produce therapeutic benefit, but low enough to avoid unacceptable levels of cytotoxicity. | 2017-09-28 |
20170273902 | Method for manufacturing medicated chewing gum without cooling - An improved method for manufacture of chewing gums containing active ingredient(s) that preserves the efficacy of the active ingredient(s) by avoiding exposure to high heat and extreme cold during milling that can otherwise degrade the active's efficacy. A chewing gum base is used, along with one or more therapeutically-active ingredients, one or more sweeteners (alcohol-based and/or natural), and one or more flavorings and optional flavor modifiers. The method generally comprises heating the gum base in ovens to melt the gum base. Separately, the active ingredient(s), sweeteners and flavorings are combined in a mixer. The melted gum base is added to the mixer and cools to produce a particulate mixture. As mixing continues the mass cools to room temperature and forms granular pieces. The granular pieces are ground into a powder at room temperature, mixed at room temperature with tableting excipients, and tableted. Several variations on the foregoing are also described. | 2017-09-28 |
20170273903 | Method for manufacturing medicated chewing gum without cooling - An improved method for manufacture of chewing gums containing active ingredient(s) that preserves the efficacy of the active ingredient(s) by avoiding exposure to high heat and extreme cold during milling that can otherwise degrade the active's efficacy. A chewing gum base is used, along with one or more therapeutically-active ingredients, one or more sweeteners (alcohol-based and/or natural), and one or more flavorings and optional flavor modifiers. The method generally comprises heating the gum base in ovens to melt the gum base. Separately, the active ingredient(s), sweeteners and flavorings are combined in a mixer. The melted gum base is added to the mixer and cools to produce a particulate mixture. As mixing continues the mass cools to room temperature and forms granular pieces. The granular pieces are ground into a powder at room temperature, mixed at room temperature with tableting excipients, and tableted. Several variations on the foregoing are also described. | 2017-09-28 |
20170273904 | PARENTERAL BIOACTIVE SUBSTANCE DELIVERY COMPOSITION BASED ON LOW MOLECULAR WEIGHT METHYL CELLULOSE - The present invention relates to a parenteral bioactive substance delivery composition and a bioactive substance carrier using a micelle based on low molecular weight methyl cellulose with a weight average molecular weight of 6 to 9.5 kDa. The bioactive substance carrier according to the present invention can completely resolve a problem of excretion to outside the body which cannot be resolved by conventional low molecular weight methyl cellulose having a weight average molecular weight of 10 to 20 kDa to increase safety and form a micelle to enable the solubilization of poorly soluble drugs, and thus is expected to be very useful for sustained release parenteral drug delivery. | 2017-09-28 |
20170273905 | LIPID MEMBRANE STRUCTURE FOR siRNA INTRACELLULAR DELIVERY - A lipid membrane structure encapsulating an siRNA inside thereof and containing a lipid compound of the formula (I) as a lipid component (R | 2017-09-28 |
20170273906 | TARGETED LIPOSOMES ENCAPSULATING IRON COMPLEXES AND THEIR USES - Provided are liposomes including a lipid membrane enclosing an intraliposomal compartment. The liposomes may encapsulate an iron complex, including an iron moiety and a macromolecule, in the intraliposomal compartment. The liposomes may additionally have a targeting moiety associated with the liposomal membranes. The targeting moiety may be exposed at the liposome's outer surface. The liposomes exhibit an immunomodulatory effect or anti-cancer effect depending on the molar ratio between the lipids forming the lipid membrane and the iron complex. As such, the liposomes can be used to treat types of inflammation, particularly inflammations that are not associated or caused by infection or be used to treat cancer. Further provided are compositions including the disclosed liposomes, methods of using and kits including the liposomes. | 2017-09-28 |
20170273907 | STABLE FORMULATIONS OF LIPIDS AND LIPOSOMES - The present invention related to aqueous lipid and/or liposome formulations with an increased chemical stability, to methods of preparing such aqueous formulations as well as to kits comprising them. The present invention further relates to methods of preparing lipid-based pharmaceutical compositions, to pharmaceutical compositions prepared by such methods and to methods of chemically stabilizing aqueous lipid and/or liposome formulations. | 2017-09-28 |
20170273908 | CROSS-LINKED POLYMER PARTICLES - Biodegradable cross-linked particles, as well as related compositions and methods, are disclosed. | 2017-09-28 |
20170273909 | COMPOSITIONS FOR STABILIZING AND DELIVERING PROTEINS - Compositions for stabilizing and delivering proteins and/or other bioactive agents are disclosed. The bioactive agents are embedded or encapsulated in a crystalline matrix. Typically the bioactive agents are in the form of micro- or nanoparticles. The crystalline matrix confers enhanced stability to the agents embedded therein relative to other microparticulate or nanoparticulate bioactive agents. The carriers are especially useful for stabilizing bioactive macromolecules, such as proteins. | 2017-09-28 |
20170273910 | ALKYL CELLULOSE FOR USE IN TABLETING AND SOLID PREPARATION COMPRISING SAME - Provided are an alkyl cellulose excellent in formability when added even in a small amount and not causing marked delay in disintegration; a solid preparation comprising it; and a method for producing the solid preparation. More specifically, provided are an alkyl cellulose for use in tableting, the alkyl cellulose having a specific surface area of from 0.5 to 10.0 m | 2017-09-28 |
20170273911 | INJECTABLE MICROSPHERES - An injectable composition for intravascular delivery of a therapeutic agent includes one or more first microspheres containing a first therapeutic agent, one or more second microspheres containing a second therapeutic agent, and a liquid carrier. The first microspheres includes a wall comprising a biodegradable polymer that encapsulates the first therapeutic agent and the second microspheres includes a wall comprising the biodegradable polymer that encapsulates the second therapeutic agent. | 2017-09-28 |
20170273912 | METHODS AND FORMULATIONS FOR SUPPORTING AND PROMOTING BONE HEALTH - Pharmaceutical formulations of β-Caryophyllene, and methods of supporting and promoting bone health using β-Caryophyllene, are described. | 2017-09-28 |
20170273913 | USE OF ONE OR A COMBINATION OF PHYTO-CANNABINOIDS IN THE TREATMENT OF EPILEPSY - This invention relates to the use of one or more cannabinoids in the treatment of epilepsy and more particularly to the use of one or a combination of cannabinoids in the treatment of generalized or partial seizure. In one embodiment it relates to the use of the cannabinoid THCV, as a pure or isolated compound, or as a plant extract in which significant amounts of any THC naturally present has been selectively removed. In another embodiment the phytocannabinoid is CBD. | 2017-09-28 |
20170273914 | DEVICE WITH COMPOSITIONS FOR DELIVERY TO THE LUNGS, THE ORAL MUCOSA AND THE BRAIN - The present invention provides a passive inhaler for use in treating a number of diseases. The inventor has shown that the compositions comprised in the inhaler can be delivered to the lungs and to the brain in pharmacological relevant dosages, to treat a number of diseases in the lungs and the brain. Further, the inhaler is also able to deliver substances to the brain which may enhance transport across the blood brain barrier. | 2017-09-28 |
20170273915 | SPECIFIC MTOR INHIBITORS IN THE TREATMENT OF X-LINKED ADRENOLEUKODYSTROPHY - The invention relates to novel uses of specific mTOR inhibitors as a medicament, in particular for the treatment of X-linked adrenoleukodystrophy (X-ALD). The invention also relates to a method for identifying a compound potentially useful for the treatment and/or prevention of X-ALD. | 2017-09-28 |
20170273916 | METHODS FOR TREATING AND PREVENTING NEURODEGENERATIVE DISEASES - The present invention provides a method for treating and preventing neurodegenerative diseases, comprising administering an effective amount of a compound isolated from | 2017-09-28 |
20170273917 | NMDA RECEPTOR ANTAGONISTS FOR TREATING GAUCHER DISEASE - The present invention provides pharmaceutical compositions comprising at least one NMDA receptor antagonist for use in treating neuropathic forms of Gaucher Disease (nGD). | 2017-09-28 |
20170273918 | PHARMACEUTICAL COMPOSITIONS FOR N-PROPARGYLAMINE DERIVATIVE - The present application relates to a method of treating Parkinson's disease by administering a mouth-dissolving composition of N-propargylamine derivative, such as rasagiline or a pharmaceutically-acceptable salt thereof. | 2017-09-28 |
20170273919 | NEW THERAPEUTIC APPROACHES FOR TREATING PARKINSON'S DISEASE - The present invention relates to compositions and methods for the treatment of Parkinson's disease and related disorders. More specifically, the present invention relates to novel combinatorial therapies of Parkinson's disease and related disorders targeting the alpha-synuclein aggregation network. In particular, the invention relates to compounds which, alone or in combination(s), can effectively protect neuronal cells from alpha-synuclein aggregates. The invention also relates to methods of producing a drug or a drug combination for treating Parkinson's disease and to methods of treating Parkinson's disease or a related disorder. | 2017-09-28 |
20170273920 | PARTICULATE MATERIALS - The present invention relates to active substances in particulate form, to methods for preparing them and to their uses. The present invention provides particulate powders, such as might be of use for delivery using a dry powder inhaler (DPI) or similar delivery device, having properties which may be beneficial to the DPI delivery process. | 2017-09-28 |
20170273921 | 3,5,N-TRIHYDROXY-ALKANAMIDE OR 3,5,N-TRIHYDROXY-6-ALKENAMIDE DERIVATIVE ALONE OR IN COMBINATION WITH CHEMOTHERAPEUTIC AGENT FOR TREATING CANCER - The present invention provides a novel method for treating cancer that comprises administering a compound represented by formula (I) and/or a chemotherapeutic agent to a subject. The present invention further provides a novel kit that comprises a compound represented by formula (I) and a chemotherapeutic agent for treating cancer. | 2017-09-28 |
20170273922 | UREA AND BIS-UREA BASED COMPOUNDS AND ANALOGUES THEREOF USEFUL IN THE TREATMENT OF ANDROGEN RECEPTOR MEDIATED DISEASES OR DISORDERS - Urea-based and bis-urea based compounds and analogues thereof are disclosed. These compounds are useful in the treatment of androgen-dependent diseases or disorders and androgen receptor-mediated diseases or disorders. Specifically, the compounds are useful in the treatment of diseases or disorders that are AR negative. | 2017-09-28 |
20170273923 | METHOD OF ADMINISTERING DIVALPROEX - A compact sustained release tablet comprising divalproex or its pharmaceutically acceptable salts as a sole active ingredient is present in an amount equivalent to from about 700 mg to about 1500 mg of valproic acid and pharmaceutically acceptable tablet excipients; wherein weight ratio of pharmaceutically acceptable tablet excipients to divalproex and/or its salt is less than 1, the tablet is suitable for once a day administration and when orally administered, with or without food, the ratio of mean AUC | 2017-09-28 |
20170273924 | VALPROATE AS A TOPICAL ANTI-FUNGAL TREATMENT - Valproate is useful as an antifungal agent. The valproate compositions can be used to treat fungal infections. The valproate compositions can be formulated as topical antifungals. | 2017-09-28 |
20170273925 | CO-ADMINISTRATION OF INTRAVENOUS IBUPROFEN AND ACETAMINOPHEN FOR TREATMENT OF PAIN - An effective dose of intravenous ibuprofen administered co-adminstered with intravenous acetaminophen in surgery patients is a safe and effective way to reduce both pain and the need for opioid analgesics. In preferred embodiments, the administration of intravenous ibuprofen and intravenous acetaminophen starts no later than at approximately the completion of wound closure. | 2017-09-28 |
20170273926 | COMPOSITIONS AND METHODS FOR USE OF EFLORNITHINE AND DERIVATIVES AND ANALOGS THEREOF TO TREAT CANCERS, INCLUDING GLIOMAS - Eflornithine is an agent that can be used to treat glioma, especially glioma of WHO Grade II or Grade III such as anaplastic glioma. Eflornithine can suppress or prevent mutations in glioma which can cause the glioma to progress to a higher grade. Compositions and methods can include eflornithine or a derivative or analog of eflornithine, together with other agents such as conventional anti-neoplastic agents for treatment of glioma, inhibitors of polyamine transport, polyamine analogs, or S-adenosylmethionine decarboxylase inhibitors. | 2017-09-28 |
20170273927 | METHODS OF TREATING AUTOIMMUNITY - Methods of treating, ameliorating, or inhibiting the development of autoimmune diseases by modulating the binding of MHC class II molecules to antigenic peptides or fragments of antigenic peptides of the autoimmune disease. The binding may be modulated by the administration of D-α-methyldopa, or pharmaceutical compositions comprising therapeutically effective amounts of D-α-methyldopa. | 2017-09-28 |
20170273928 | COMPOSITION FOR PREVENTING THE OCCURRENCE OF CARDIOVASCULAR EVENT IN MULTIPLE RISK PATIENT - Disclosed is a composition which is useful for preventing the occurrence of a cardiovascular event, particularly a composition which is expected to show a prophylactic effect on a cardiovascular event occurring in a hypercholesterolemia patient despite providing the patient with a treatment with HMG-CoA RI or a cardiovascular event occurring in a multiple risk patient. | 2017-09-28 |
20170273929 | CARDIOVASCULAR DISEASE PRIMARY PREVENTION AGENT FOR PATIENTS HAVING HIGH BLOOD LEVELS OF HIGH-SENSITIVITY C-REACTIVE PROTEIN - The present invention provides the following: a cardiovascular disease primary prevention agent, which comprises as the active ingredient at least one selected from the group consisting of EPA, salts thereof, and esters thereof and is for lowering the risk of cardiovascular disease by administration to subjects having a blood (serum or plasma) hs-CRP level of 1.0 mg/L or higher in spite of no history of cardiovascular disease; a combination marker comprising the blood hs-CRP value and serum EPA/AA ratio for evaluating the primary risk of cardiovascular disease in subjects having no history of cardiovascular disease; and a method for extracting subjects with high risk of cardiovascular disease and/or a method for preventing cardiovascular disease. | 2017-09-28 |
20170273930 | METHODS TO TREAT NEURODEGENERATIVE DISEASES - The specification provides compositions and methods to treat neurodegenerative diseases. | 2017-09-28 |
20170273931 | COMPOSITION COMPRISING A COMPOUND FROM THE FAMILY OF AVERMECTINS AND DOXYCYCLINE FOR THE TREATMENT OF ROSACEA - The use of a composition comprising a compound from the family of avermectins, preferably ivermectin, and doxycycline or one of the salts thereof that is pharmaceutically acceptable in the treatment and/or slowing of the appearance of the symptoms of rosacea is described. | 2017-09-28 |
20170273932 | LYOPHILIZED COMPOSITIONS CONTAINING A METAP-2 INHIBITOR - This disclosure features compositions (e.g., re-constitutable solids, such as lyophilized cakes; or liquid compositions, such as solutions or suspensions, e.g., reconstituted lyophilized cakes) that are suitable for subcutaneous administration. The compositions include a crystalline form (e.g., Form A) of 6-O-(4-dimethylaminoethoxy)cinnamoyl fumagillol, free base and one or more pharmaceutically acceptable excipients and/or one or more pharmaceutically acceptable carriers (e.g., one or more bulking agents; one or more dispersing agents; one or more buffers; one or more suspending agents; water, e.g., water for injection (“WFI”)). | 2017-09-28 |
20170273933 | ANTI-TUMOR COMPOUND AND THE MEDICAL USE THEREOF - The invention disclose a compound of formula (I), wherein, R | 2017-09-28 |